about
Beneficial effect of an antibody against interleukin-2 receptor (daclizumab) in an experimental model of hepatocyte xenotransplantation.Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.Basic immunosuppressive drugs outside solid organ transplantation.Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Novel therapies in transplantation.
@ast
Novel therapies in transplantation.
@en
type
label
Novel therapies in transplantation.
@ast
Novel therapies in transplantation.
@en
prefLabel
Novel therapies in transplantation.
@ast
Novel therapies in transplantation.
@en
P2860
P1476
Novel therapies in transplantation.
@en
P2093
Anamaria Jorga
Atholl Johnston
P2860
P304
P356
10.1517/13543784.14.3.295
P407
P577
2005-03-01T00:00:00Z